MoneyWorks4Me

NATCO Pharma informs about press release

25 Jul 2022 Evaluate

NATCO Pharma has informed that it enclosed the press release today titled ‘NATCO Announces Approval of its ANDA for Cabazitaxel Intravenous Solution (generic for Jevtana Kit®)’ under Regulation 30 of SEBI (LODR) Regulations 2015 for the information.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..